Stryker Corporation logo

Stryker Corporation (SYK)

Market Closed
11 Jul, 20:00
NYSE NYSE
$
389. 46
-5.31
-1.35%
$
150B Market Cap
43.11 P/E Ratio
3.2% Div Yield
825,100 Volume
10.41 Eps
$ 394.77
Previous Close
Day Range
387.44 392.99
Year Range
314.93 406.19
Want to track SYK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 15 days
SYK Stock Declines Despite Steri-Shield Launch to Boost OR Portfolio

SYK Stock Declines Despite Steri-Shield Launch to Boost OR Portfolio

Stryker launches Steri-Shield 8, a cutting-edge PPE system with enhanced fit, visibility and protection, reinforcing its leadership in medical safety.

Zacks | 4 months ago
SYK Stock Gains on Launch of Hands-Free Device: Sync Badge

SYK Stock Gains on Launch of Hands-Free Device: Sync Badge

Stryker's Sunc Badge is a Hands-free, wearable communication device that will support care team members with fast and reliable collaboration. It is likely to help offset the ongoing nurse shortage.

Zacks | 4 months ago
Stryker Corporation (SYK) Citi's 2025 Unplugged Medtech and Life Sciences Access Day (Transcript)

Stryker Corporation (SYK) Citi's 2025 Unplugged Medtech and Life Sciences Access Day (Transcript)

Stryker Corporation (NYSE:SYK ) Citi's 2025 Unplugged Medtech and Life Sciences Access Day February 27, 2025 12:15 PM ET Company Participants Preston Wells - CFO Jason Beach - VP, Finance, IR Conference Call Participants Joanne Wuensch - Citigroup Joanne Wuensch Joanne Wuensch, the medical technology analyst here at Citi Bank. So for our next session, I'm quite thrilled to have the incoming CFO, Preston Wells and Jason Beach, which I think people know quite well.

Seekingalpha | 4 months ago
SYK Trades Below 52-Week High: Should You Buy, Hold or Sell the Stock?

SYK Trades Below 52-Week High: Should You Buy, Hold or Sell the Stock?

Stryker is gaining momentum with strong Q4 results, innovative medtech solutions and high-growth market expansion. But, is the stock still a buy?

Zacks | 4 months ago
Sales Growth, Strategic Acquisitions Drive Stryker Higher

Sales Growth, Strategic Acquisitions Drive Stryker Higher

Medical device maker Stryker Corporation (SYK) benefits from more procedures, sales, and acquisitions.

Fxempire | 5 months ago
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth

Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth

Wall Street analysts rerated Stryker Corp SYK Wednesday after the company's fourth-quarter print.

Benzinga | 5 months ago
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth

Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth

Wall Street analysts rerated Stryker Corp SYK Wednesday after the company's fourth-quarter print.

Benzinga | 5 months ago
Stryker Stock Falls on Deal to Sell Its U.S. Spinal Implants Business

Stryker Stock Falls on Deal to Sell Its U.S. Spinal Implants Business

SYK announces agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC.

Zacks | 5 months ago
SYK Stock Down Despite Q4 Earnings Beat and Spine Biz Divestment Plans

SYK Stock Down Despite Q4 Earnings Beat and Spine Biz Divestment Plans

SYK's fourth-quarter results reflect strong segmental performance, along with a rise in operating margin.

Zacks | 5 months ago
Stryker Corporation (SYK) Q4 2024 Earnings Conference Call Transcript

Stryker Corporation (SYK) Q4 2024 Earnings Conference Call Transcript

Stryker Corporation (NYSE:SYK ) Q4 2024 Earnings Conference Call January 28, 2025 4:30 PM ET Company Participants Kevin Lobo - Chairman, CEO & President Andy Pierce - Group President of MedSurg & Neurotechnology Jason Beach - Vice President, Finance and Investor Relations Glenn Boehnlein - Vice President, Chief Financial Officer Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Robert Marcus - JPMorgan Travis Steed - Bank of America David Roman - Goldman Sachs Pito Chickering - Deutsche Bank Vijay Kumar - Evercore ISI Matthew O'Brien - Piper Sandler Companies Shagun Singh - RBC Matthew Miksic - Barclays Michael Matson - Needham & Company Caitlin Cronin - Canaccord Genuity Richard Newitter - Truist Securities Josh Jennings - TD Cowen Danielle Antalffy - UBS Equities Michael Polark - Wolfe Research Operator Welcome to the Fourth Quarter 2024 Stryker Earnings Call. My name is Luke, and I'll be your operator for today's call.

Seekingalpha | 5 months ago
Stryker (SYK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Stryker (SYK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 5 months ago
Stryker (SYK) Q4 Earnings and Revenues Surpass Estimates

Stryker (SYK) Q4 Earnings and Revenues Surpass Estimates

Stryker (SYK) came out with quarterly earnings of $4.01 per share, beating the Zacks Consensus Estimate of $3.87 per share. This compares to earnings of $3.46 per share a year ago.

Zacks | 5 months ago
Loading...
Load More